通过捐赠者干预改善肝移植结果?
Amelia J Hessheimer1, Eva Flores2, Jordi Vengohechea1
1General & Digestive Surgery Service, Hospital Universitario La Paz, IdiPAZ, CIBERehd.
Current opinion in organ transplantation
|May 24, 2024
概括
捐赠者干预可以改善肝移植的移植产量和结果. 脑死亡后的捐赠策略,血液循环确定死亡后的捐赠策略和活着的捐赠者优化了移植质量和接受者成功.
科学领域:
- 移植研究 移植研究
- 器官捐献科学 器官捐献科学
- 图形优化优化 图形优化
背景情况:
- 捐赠者因素显著影响肝移植的数量和质量,影响移植等候名单的需求.
- 捐赠者干预为减轻捐赠过程中固有的风险和伤害提供了关键途径.
研究的目的:
- 审查和划分优化肝脏捐献结果的关键问题.
- 针对脑死亡 (DBD) 后的捐赠,循环死亡 (DCD) 后的捐赠和活体捐赠者 (LD) 的具体考虑.
主要方法:
- 审查有关捐赠者管理实践和干预措施的现有文献.
- 分析DBD,DCD和LD场景中使用的策略.
主要成果:
- 具体干预的证据有限,但DBD中使用临床关怀原则来管理血液动力学不稳定性和低输液.
- 在DCD中,干预的重点是限制和逆转热性缺血.
- 饮食,运动和最少的侵入性技术显示出改善活体捐赠者的结果的希望.
结论:
- 捐赠者干预对于提高肝移植成功率至关重要.
- 优化捐赠者管理直接改善了捐赠者和接受者的移植产量和结果.
相关概念视频
Tissue Transplantation
358
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
358
Bone Marrow Sampling and Transplants
324
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
324


